Primary Human Colonic Mucosal Barrier Crosstalk with Super Oxygen-sensitive in Continuous Culture
Overview
Authors
Affiliations
Background: The gut microbiome plays an important role in human health and disease. Gnotobiotic animal and cell-based models provide some informative insights into mechanistic crosstalk. However, there is no existing system for a long-term co-culture of a human colonic mucosal barrier with super oxygen-sensitive commensal microbes, hindering the study of human-microbe interactions in a controlled manner.
Methods: Here, we investigated the effects of an abundant super oxygen-sensitive commensal anaerobe, on a primary human mucosal barrier using a Gut-MIcrobiome (GuMI) physiome platform that we designed and fabricated.
Findings: Long-term continuous co-culture of for two days with colon epithelia, enabled by continuous flow of completely anoxic apical media and aerobic basal media, resulted in a strictly anaerobic apical environment fostering growth of and butyrate production by , while maintaining a stable colon epithelial barrier. We identified elevated differentiation and hypoxia-responsive genes and pathways in the platform compared with conventional aerobic static culture of the colon epithelia, attributable to a combination of anaerobic environment and continuous medium replenishment. Furthermore, we demonstrated anti-inflammatory effects of through HDAC and the TLR-NFKB axis. Finally, we identified that butyrate largely contributes to the anti-inflammatory effects by downregulating TLR3 and TLR4.
Conclusions: Our results are consistent with some clinical observations regarding thus motivating further studies employing this platform with more complex engineered colon tissues for understanding the interaction between the human colonic mucosal barrier and microbiota, pathogens, or engineered bacteria.
Physiologically Relevant Coculture Model for Oral Microbial-Host Interactions.
Pang Z, Cady N, Cen L, Schmidt T, He X, Li J bioRxiv. 2025; .
PMID: 39868140 PMC: 11761807. DOI: 10.1101/2025.01.10.632380.
Song S, Ning L, Yu J Front Endocrinol (Lausanne). 2025; 15():1391891.
PMID: 39845884 PMC: 11750691. DOI: 10.3389/fendo.2024.1391891.
Garcia Mansilla M, Rodriguez Sojo M, Lista A, Ayala Mosqueda C, Ruiz Malagon A, Galvez J Nutrients. 2025; 17(1.
PMID: 39796588 PMC: 11723002. DOI: 10.3390/nu17010155.
Floor E, Su J, Chatterjee M, Kuipers E, Ijssennagger N, Heidari F Gut Microbes. 2024; 17(1):2434685.
PMID: 39714032 PMC: 11702969. DOI: 10.1080/19490976.2024.2434685.
Randall-Demllo S, Al-Qadami G, Raposo A, Ma C, Priebe I, Hor M Cancers (Basel). 2024; 16(21).
PMID: 39518102 PMC: 11544769. DOI: 10.3390/cancers16213664.